Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Insmed (INSM)
NASDAQ:INSM
Insmed (INSM) Stock Forecast & Price Target
675 Followers
See the Price Targets and Ratings of:
INSM Analyst Ratings
Strong Buy
16 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
INSM Stock 12 Month Forecast
Average Price Target
$81.54
▲(7.33% Upside)
| Highest Price Target$102.00 | Average Price Target$81.54 | Lowest Price Target$54.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Morgan Stanley
Reiterated
07/12/24
Barclays
Assigned
07/12/24
Goldman Sachs
Reiterated
07/10/24
Guggenheim
Reiterated
07/09/24
Truist Financial
Assigned
07/08/24
H.C. Wainwright
Reiterated
07/08/24
Mizuho Securities
Reiterated
07/08/24
Bank of America Securities
Assigned
07/05/24
TD Cowen
Assigned
07/05/24
Evercore ISI
Reiterated
07/05/24
Leerink Partners
―
Buy
―
Reiterated
07/03/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (NASDAQ: CVAC), Insmed (NASDAQ: INSM) and Quest Diagnostics (NYSE: DGX)
J.P. Morgan
―
Buy
―
Reiterated
07/03/24
Brensocatib's Promising Phase III Results Justify Buy Rating for Insmed
UBS
$58→$78
Buy
$78.00
(2.67% Upside)
Reiterated
06/05/24
Insmed (INSM) PT Raised to $78 at UBSUBS analyst Trung Huynh raised the price target on Insmed (NASDAQ: INSM) to $78.00 (from $58.00) while maintaining a Buy rating.
Stifel Nicolaus
$67→$74
Buy
$74.00
(-2.59% Downside)
Reiterated
06/05/24
Insmed price target raised to $74 from $67 at StifelInsmed price target raised to $74 from $67 at Stifel
Wells Fargo
$77
Buy
$77.00
(1.36% Upside)
Reiterated
06/04/24
Strong Buy Rating for Insmed Amid High Commercial Prospects for Brensocatib and Promising TPIP Future
Best Analysts Covering Insmed
Which Analyst Should I Follow If I Want to Buy INSM and Sell After:
1 Month
xxx
Success Rate
6/10 ratings generated profit
Average Return
+16.73%
assigned a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +16.73% per trade.
3 Months
xxx
Success Rate
11/13 ratings generated profit
Average Return
+45.96%
assigned a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 84.62% of your transactions generating a profit, with an average return of +45.96% per trade.
1 Year
Success Rate
13/13 ratings generated profit
Average Return
+128.26%
assigned a buy rating 17 days ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +128.26% per trade.
2 Years
xxx
Success Rate
10/10 ratings generated profit
Average Return
+213.28%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +213.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
INSM Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
12
12
15
13
10
Buy
15
10
21
37
51
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
27
22
36
50
61
Each month's total comprises the sum of three months' worth of ratings.
INSM Financial Forecast
INSM Stock Forecast FAQ
What is INSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Insmed’s 12-month average price target is $81.54.
What is INSM’s upside potential, based on the analysts’ average price target?
Insmed has 7.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INSM a Buy, Sell or Hold?
Insmed has a consensus rating of Strong Buy which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
What is Insmed’s price target?
The average price target for Insmed is $81.54. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $102.00 ,the lowest forecast is $54.00. The average price target represents 7.33% Increase from the current price of $75.97.
The highest analyst price target is $102.00 ,the lowest forecast is $54.00. The average price target represents 7.33% Increase from the current price of $75.97.
What do analysts say about Insmed?
Insmed’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of INSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.